The present invention provides methods and compositions for inhibiting
influenza infection and/or replication based on the phenomenon of RNA
interference (RNAi) well as systems for identifying effective siRNAs and
shRNAs for inhibiting influenza virus and systems for studying influenza
virus infective mechanisms. The invention also provides methods and
compositions for inhibiting infection, pathogenicity and/or replication
of other infectious agents, particularly those that infect cells that are
directly accessible from outside the body, e.g., skin cells or mucosal
cells. In addition, the invention provides compositions comprising an
RNAi-inducing entity, e.g., an siRNA, shRNA, or RNAi-inducing vector
targeted to an influenza virus transcript and any of a variety of
delivery agents. The invention further includes methods of use of the
compositions for treatment of influenza.